Lavaca Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,400
Closed -$1.1M 156
2022
Q2
$1.1M Sell
3,400
-1,500
-31% -$450K 0.16% 66
2022
Q1
$1.4M Buy
4,900
+200
+4% +$51.5K 0.15% 71
2021
Q4
$1.3M Sell
4,700
-200
-4% -$50.7K 0.17% 67
2021
Q3
$1.13M Sell
4,900
-300
-6% -$74K 0.11% 74
2021
Q2
$1.19M Buy
+5,200
New +$1.04M 0.12% 68

Other funds holding LLY

Lavaca Capital's LLY Position: Q1 2026 in Review

Lavaca Capital held its Eli Lilly (LLY) position steady in Q1 2026 at 386 shares worth $355K. The position accounts for 0.06% of the portfolio, ranked #81.

Lavaca Capital first reported a position in LLY in Q4 2018 and has held it in 25 quarters since. The position peaked at $3.71M in Q4 2021. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Lavaca Capital held 386 shares of Eli Lilly worth $355K as of Q1 2026.
  • Lavaca Capital left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.06% of Lavaca Capital's portfolio in Q1 2026, its #81 holding.
  • Lavaca Capital first reported a position in Eli Lilly in Q4 2018 and has held it in 25 quarters since.
  • Lavaca Capital's Eli Lilly position peaked at $3.71M in Q4 2021.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Lavaca Capital's 13F filing for Q1 2026, filed 13 May 2026.